Hatch to POTUS: Time to Stop Using Tariffs and Start Negotiating

Finance Committee Chairman Orrin Hatch (R-Utah) emphasizes the economic harm tariffs create during a Senate floor speech on Tuesday. WASHINGTON – Senate Finance Committee Chairman Orrin Hatch (R-Utah) today urged the administration to rethink its global trade strategy during a speech on the Senate floor, emphasizing that it could undermine the success of tax reform. […]

Hatch Announces Markup of IRS Commissioner Nominee

WASHINGTON – Senate Finance Committee Chairman Orrin Hatch (R-Utah) today announced that the committee will convene a markup on the nomination of Charles Rettig to be commissioner of the Internal Revenue Service (IRS). The markup will occur on Thursday, July 19 at 10 a.m. in 215 Dirksen Senate Office Building. The committee will markup the […]

Hatch Statement on Additional $200 Billion in Tariffs Under Section 301

WASHINGTON – Senate Finance Committee Chairman Orrin Hatch (R-Utah) today released the following statement regarding the administration’s announcement that additional tariffs on $200 billion of Chinese products will be imposed under Section 301 of the Trade Act of 1974: “Although I have supported the administration’s targeted efforts to combat China’s technology transfer regime, tonight’s announcement […]

Victories Abound for Senate Finance Committee

The Senate Finance Committee has been busy, very busy, throughout the 115th Congress. With a new Republican administration, the committee under the leadership of Chairman Orrin Hatch (R-Utah), spearheaded the biggest tax overhaul in more than 30 years, chipped away at Obamacare, secured bipartisan health care accomplishments, and it’s showing no signs of slowing down […]

Finance Committee Advances Commerce, HHS & Tax Court Nominees

WASHINGTON – The Senate Finance Committee today advanced the nominations of Jeffrey Kessler to be an Assistant Secretary of Commerce, Lynn A. Johnson to be Department of Health and Human Services Assistant Secretary for Family Support, Elizabeth Ann Copeland to be a United States Tax Court Judge, and Patrick J. Urda to be a United […]

Hatch Opening Statement at Rettig Nomination Hearing

WASHINGTON – Senate Finance Committee Chairman Orrin Hatch (R-Utah) today delivered the following opening statement at a hearing to consider the nomination of Charles Rettig to be the Internal Revenue Service (IRS) Commissioner:  Right now, the IRS is at a critical juncture. The American people are already seeing myriad of benefits thanks to tax reform […]

Hatch Announces New Finance Committee Majority Staff Director

WASHINGTON – Senate Finance Committee Chairman Orrin Hatch (R-Utah) today announced that that Dr. Jeff Wrase will take on a new role as the majority’s staff director. After seven years with the Finance Committee, current staff director Jay Khosla will be departing the committee.  Khosla joined the Finance Committee in 2011 as Chief Health Counsel and […]

Hatch Statement on Administration’s Investment Restrictions Announcement

Utah Senator Says, “Both the president and Congress are determined to combat China’s discriminatory and market-distorting activities, and today’s action is another step in that joint commitment.”  WASHINGTON – Senate Finance Committee Chairman Orrin Hatch (R-Utah) today released the following statement on the administration’s announcement regarding foreign investment, Section 301 of the Trade Act of […]

Hatch Opening Statement at Drug Affordability and Innovation Hearing

WASHINGTON – Senate Finance Committee Chairman Orrin Hatch (R-Utah) today delivered the following opening statement at a hearing on drug pricing and innovation with Health and Human Services (HHS) Secretary Alex Azar:  We are pleased to have Secretary Azar appear before the committee today, and I know members on both sides of the aisle are […]

Roll Call Opinion: To Keep Drug Costs Low, Think Competition, Not Price Controls

By Senate Finance Committee Chairman Orrin Hatch (R-Utah) Even in today’s highly partisan environment, there’s one thing nearly all Americans agree on: The soaring cost of prescription drugs is alarming. In fact, 80 percent of Americans consider the cost of prescription drugs unreasonable. At the same time, a majority of Americans recognize that prescription drugs have improved countless lives. […]